TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

2020-10-15

Blood Advances , Volume 4 - Issue 20 p. 5011- 5024

Additional Metadata
Persistent URL	doi.org/10.1182/bloodadvances.2020002512, hdl.handle.net/1765/131653
Journal	Blood Advances
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Vadakekolathu, J., Lai, C., Reeder, S., Church, S.E., Hood, T., Lourdusamy, A., … Rutella, S. (2020). TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML. Blood Advances, 4(20), 5011–5024. doi:10.1182/bloodadvances.2020002512

Publication